Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126037151 | 12603715 | 1 | I | 201506 | 20150708 | 20160728 | 20160728 | PER | US-MYLANLABS-2015M1023262 | MYLAN | 69.77 | YR | F | Y | 0.00000 | 20160728 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126037151 | 12603715 | 1 | PS | Levothyroxine Sodium Tablets, USP | LEVOTHYROXINE SODIUM | 1 | Oral | 50 ?G, QD | 76187 | 50 | UG | TABLET | QD | ||||||
126037151 | 12603715 | 2 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126037151 | 12603715 | 1 | Hypothyroidism |
126037151 | 12603715 | 2 | Vertigo |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126037151 | 12603715 | Abdominal discomfort | |
126037151 | 12603715 | Blood glucose fluctuation | |
126037151 | 12603715 | Dyspepsia | |
126037151 | 12603715 | Headache | |
126037151 | 12603715 | Musculoskeletal discomfort | |
126037151 | 12603715 | Urine output decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126037151 | 12603715 | 1 | 20150629 | 0 |